Blockchain Registration Transaction Record

LataMed AI Corp. Announces Effectiveness of 5-for-1 Forward Stock Split

LataMed AI Corp. announces effectiveness of 5-for-1 forward stock split, trading under LMEDD. New CUSIP 21116R404. CEO highlights AI platforms CardioAI, PulmoAI, NeuroAI. Telemedicine expansion in Latin America.

This news matters because the forward stock split and share exchange signal a strategic move by LataMed AI to restructure its capital and potentially increase liquidity and marketability of its shares. For investors, this corporate action may affect share price and trading volume, making it crucial to understand the new CUSIP and temporary symbol. The company's continued focus on AI-driven healthcare platforms like CardioAI, PulmoAI, and NeuroAI underscores its commitment to emerging markets, which could impact healthcare access in underserved regions. Shareholders should monitor the transition period and ensure their holdings are correctly processed.